|Home | About | Journals | Submit | Contact Us | Français|
Despite the growing appreciation of the importance of sex and gender considerations in transplantation research, there is currently no framework or good practice guidelines for the appropriate handling of sex and gender issues in human allotransplantation research.
We will conduct a scoping review to synthesize the evidence on how matters of sex and gender have been handled in human allotransplantation research. We will survey the literature discussing sex and gender in relation to transplantation, including adult and pediatric patients, hematopoietic and solid organ transplant recipients as well as organ donors. We will search MEDLINE and Embase for literature discussing sex and gender in relation to transplantation. Two reviewers will independently evaluate the eligibility of all identified titles and abstracts for inclusion in the full text review, as well as data extraction. Descriptive data and information on how sex and gender have been considered in human transplantation research will be reported.
This scoping review will be an important stepping stone towards the development of good practice guidelines on study design and analysis considerations when handling sex and gender issues in human transplantation research. This scoping review can also help identify methodological issues that restrict the translation of transplantation research findings into clinical practice related to underestimation of sex/gender differences. This review will ultimately identify major gaps, inform donor-recipient selection, guide personalized interventions, and prioritize research recommendations in human transplantation research.
The online version of this article (10.1186/s13643-017-0578-4) contains supplementary material, which is available to authorized users.
Sex and gender differences in medicine may contribute to disparities in disease incidence, health care system utilization, and general health outcomes. Sex represents a biological characteristic of an individual, while gender refers to the array of socially constructed roles, attitudes, personality traits, and behaviors . These concepts may be conceptually distinct, but also influence and interact with each other .
Sex- and gender-based analyses (SGBA) offer a systematic approach to examine the impact of sex and/or gender on population health-related outcomes . SGBA have been implemented in several specialties [4, 5] and have been increasingly recognized as crucial to the development of comprehensive evidence that will ultimately lead to guidelines and policies . Sex and gender are generally understudied in research, and their definitions are often inappropriately interchanged. Many studies incorrectly assume sex and gender neutrality and fail to provide separate analyses based on sex . The failure to consider sex and gender in study design and/or analysis may compromise the validity and generalizability of research findings and affect translation into clinical practice [7, 8]. Greater awareness of patients’ sex and gender will help inform personalized interventions, identify variations of care, and compare effectiveness of therapies.
In human allotransplantation, there is exchange of tissue and/or cells between donors and recipients. Health outcomes, patient experience, and health care costs related to transplantation may vary by transplant candidates’, recipients’, and donors’ sex and/or gender. For example, immune suppression metabolism may vary by sex. Transplant outcomes also vary by donor-recipient sex mismatch. However, the mechanisms leading to sex and gender disparities continue to be debated. Moreover, a marked disparity is observed in access to transplantation by sex. While this disparity may be related to greater immune sensitization in women vs. men from pregnancies, this may also be attributed to a tendency to forgo transplantation, or inability to adhere to appointment or treatment schedules, because of gender role pressure.
Despite the growing appreciation of the importance of sex and gender considerations in research in general, and in transplantation research in particular, there is currently no framework or good practice guidelines for the appropriate handling of sex and gender issues in human allotransplantation research. We will review the available transplantation literature where sex and gender issues were deemed sufficiently central in the manuscript to warrant their mentioning to achieve the following long-term goals: outline personalized strategies to improve transplant outcomes, identify variations in care, ensure equity, inform donor-recipient selection and compatibility evaluation, orient future transplantation research, and inform good practice guidelines for handling sex and gender issues in human allotransplantation research.
The overall objective of our scoping review is to comprehensively capture how matters of sex and gender have been considered in human allotransplantation research to date. Specifically, this review aims to (1) assess the published literature on the correct application of “sex” and “gender” concepts, (2) ascertain whether (and how) “sex” and “gender” were considered at the stages of study design and analysis, (3) identify the key outcomes for which effects of sex and gender variables were previously considered, and (4) disseminate our research findings. Our scoping review will adhere to the PRISMA-P checklist (Additional file 1).
To synthetize the evidence on how matters of sex and gender were handled in human allotransplantation research, we will conduct a scoping review. Scoping reviews are useful for mapping the literature particularly when there is a large body of work that exhibits a large, complex, or heterogeneous nature. While scoping reviews may be undertaken to summarize and disseminate research findings, to identify evidence gaps, to specify policy or practice recommendations, and to make recommendations for the future research, they are primarily used to clarify working definitions and conceptual boundaries of a topic or field and consider various study designs. Unlike systematic reviews, scoping reviews typically do not include a formal quality (risk of bias) appraisal [9–11]. The scoping review approach will allow us to explore the broad topic of sex and gender in relation to transplantation, including adult and pediatric patients, hematopoietic and solid organ transplant recipients, as well as organ donors. Our protocol development follows the framework outlined by Arksey and O’Mally  as well as Levac et al. , which consists of the (1) identification of the research question, (2) identification of all relevant studies, (3) selection of studies, (4) data abstraction, and (5) summary and reporting of results. Scoping reviews are not eligible for inclusion in PROSPERO. Consequently, a PROSPERO registration number is not provided.
The electronic database search strategy was developed in consultation with an information specialist. Text words and relevant indexing were used to identify articles discussing sex and/or gender issues in transplantation (hematopoietic and solid organ) and in donation. MEDLINE and Embase were searched using the following keywords: sex difference, sex, or gender (with characteristics, factor, imbalance, issue, specific) in combination with the keywords tissue, cell transplantation (tissue, cell or hematopoietic transplant, donors, donation), or organ (cardiac, heart, hematopoietic, hepatic, kidney, liver, lung, organ, pancreas, pulmonic, renal, donor, donation) transplantation. The search strategy presented in Table 1 yielded 6083 unique references.
Studies will be eligible for inclusion if they satisfy the following criteria: (1) the target population consists of humans across the age continuum undergoing stem cell (e.g., allogenic or mesenchymal), tissue (e.g., allogenic skin, bone, and cornea grafts), or solid organ transplantation in the capacity of transplant candidates, recipients, and donors; (2) sex and/or gender are mentioned in the title or abstract of the manuscript; (3) the manuscript reports original research, written in English, and published between January 1, 1946 and October 17, 2016; (4) the study design includes randomized control trials, observational studies, case series with at least 20 participants, registry/population report, validation survey, and method comparison with at least 20 participants.
Studies will be excluded if they (1) do not discuss allotransplantation (e.g. ventricular assist devices that do not serve as bridges to transplantation, vein allografts for cardiac bypass, homografts (heart valves), transfusion/donation of blood products, tumor/cancer transplants, embryo oocytes or sperm donation, brain or body donation for research, and autologous grafts), (2) do not mention sex or gender in the title and/or abstract, (3) are not original studies (letters, editorials, news, replies, comments), or (4) are conference abstracts.
Two reviewers will independently evaluate the eligibility of all identified titles and abstracts for inclusion in the full-text review. Disagreements will be resolved by consensus or by a third reviewer. Full-text articles will be evaluated for inclusion by two independent reviewers using similar inclusion and exclusion criteria (Table 1). All included studies will be synthetized and reported in a separate appendix.
Data extraction from selected full-text manuscripts will be done using Covidence, a systematic review software developed in partnership with the Cochrane Collaboration, and will comprise of two steps. First, descriptive data will be extracted into a form, which will include the variables appearing in Table Table22 (general information on the study, population, setting, study design and type, sample size, transplanted cells/tissues/organs, main outcomes, and sex- and gender-related covariates). Second, for each selected study, to evaluate how sex and gender have been considered in human transplantation research to date, two reviewers will independently extract data with disagreements when answering the following questions resolved by consensus or by a third reviewer:
We will present descriptive statistics of the study characteristics outlined in Table Table22 (e.g., by study era, country, etc.). We will summarize the proportion of manuscripts applying the term “gender” correctly as well as whether and how gender-related variables were measured and reported in the manuscript. Finally, we will provide narrative synthesis on how sex and gender were handled at the level of study design and analysis.
To our knowledge, this scoping review will be the first evaluating how sex and gender have been handled in human allotransplantation research. This review will comprehensively inform the various key players in transplantation ranging from donors, through transplant candidates and recipients, to transplant physicians and coordinators. A few foreseen limitations must be noted, however. Our selection criteria may decrease the likelihood of detecting articles discussing gender/sex concepts in transplantation when sex and gender are mentioned in the text but not in the title or abstract. Articles discussing gender-related variables without specifically using the term “gender” may not be captured. We might also exclude smaller case series, potentially leading to under-representation of less frequently transplanted cells/tissues/organs. Despite these limitations, we believe that the findings of our scoping review will be an important stepping stone towards the development of good practice guidelines on study design and analysis considerations when handling sex and gender issues in human transplantation research (Fig. 1). This scoping review will also help identify methodological issues that restrict the translation of transplantation research findings into clinical practice related to underestimation of sex/gender differences. This ultimately will serve to identify major gaps in the literature, inform donor-recipient selection, guide personalized interventions, and prioritize research recommendations in human transplantation research. Ultimately, these efforts are expected to inform personalized management that can improve health outcomes, patient experience, and health expenditure in transplant recipients.
The authors would like to acknowledge the Canadian National of Transplantation Research Program (CNTRP), as this project was conceived during the 2016 CST-CNTRP-SQT Joint Scientific Meeting. The authors would also like to acknowledge Tara Landry from the McGill University Health Centre Medical Library, who helped develop the search strategy.
C. Laprise received a postdoctoral fellowship from the Canadian Institutes of Health Research (FRN: 135506). R. Sapir-Pichhadze is funded by the KRESCNET-CIHR New Investigator Award and a KFOC Infrastructure Grant.
RSP is the guarantor of the review. CL, VSS, LW, BF, and LP participated to conception and study design. RSP, CL, and VSS drafted the manuscript, and LW, BF, and LP revised it critically for intellectual content. All authors read and approved the final version of the manuscript.
Additional file 1:(31K, docx) PRISMA-P 2015 Checklist. (DOCX 30 kb)
PRISMA-P 2015 Checklist. (DOCX 30 kb)
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
The online version of this article (10.1186/s13643-017-0578-4) contains supplementary material, which is available to authorized users.
Claudie Laprise, Email: firstname.lastname@example.org.
Vikas Srinivasan Sridhar, Email: email@example.com.
Lori West, Email: ac.atreblau@tsewjl.
Bethany Foster, Email: firstname.lastname@example.org.
Louise Pilote, Email: email@example.com.
Ruth Sapir-Pichhadze, Phone: (514) 934-1934 ext. 34359, Email: firstname.lastname@example.org.